33results about How to "Regulate physique" patented technology

The invention provides a pharmaceutical composition for treating ulcerative colitis and a micro-pill preparation with colon-targeted properties thereof, relating to the technical field of medicines. The pharmaceutical composition takes bighead atractylodes rhizome as a monarch medicine, coptis as a ministerial medicine and radix sileris as an adjuvant medicine, and is prepared from the following components in concrete parts by weight: 30-60 parts of bighead atractylodes rhizome, 30-45 parts of coptis and 30-60 parts of radix sileris. The extracts of the bighead atractylodes rhizome, coptis and radix sileris are respectively prepared into stomach-soluble micro-pills and intestine-soluble micro-pills, and then, the stomach-soluble micro-pills and the intestine-soluble micro-pills are proportionally mixed to prepare an oral colon-targeted administration system of micro-pills prepared from bighead atractylodes rhizome and coptis, thereby realizing the purpose of colon-targeted administration and better exerting the effect of the composition. The pharmaceutical composition provided by the invention and the oral colon-targeted administration system of micro-pills prepared from bighead atractylodes rhizome and coptis have the dual-treatment characteristics of treating both principal and secondary aspects of diseases and simultaneously considering overall and local aspects, and are safe and convenient in oral administration and low is cost. The animal experiment shows that the pharmaceutical composition and the oral colon-targeted administration system have an obvious treatment effect on ulcerative colitis (the treatment effect is close to or even superior to the treatment effect of a positive control medicine salicylazosulfapyridine (SASP)), and have small side effects, thus the pharmaceutical composition and the oral colon-targeted administration system can be used for preparing medicines for treating ulcerative colitis.

The invention relates to a nano-scale multifunctional liquid premixed feed and a preparation method thereof. The feed is stable, uniform and transparent liquid and is prepared by emulsifying and stabilizing various active ingredients with a surfactant and a cosurfactant in groups. The preparation process mainly has the following innovations that: the characteristic of the action among the surfactant, an emulsifying agent, a stabilizing agent, an inorganic salt and the active ingredients is skillfully utilized to effectively disperse three types of active ingredients consisting of vitamin, natural pigment and amino acid which are difficult to dissolve together in the same system; and the grains of the colloid have nano-scale sizes ranging from 20 to 60nm. The premixed feed is suitable to be used in the breeding of livestock and poultry and has the effects of meeting an emergency, preventing diseases, keeping health, fattening, effectively improving the intrinsic quality and exterior quality of the animal products and the like.

The invention discloses healthcare wine which is mainly prepared by mixing the components in parts by weight as follows: 5 kg-7.5 kg of wine, 10 g-15 g of Chinese caterpillar fungus, 20 g-25 g of corn cervi pantotrichum, 50 g-60 g of American ginseng, 50 g-60 g of Korean ginseng, 40 g-60 g of ginseng, 6 g-8 g of hippocamp, 50 g-60 g of fructus lycii, 15 g-20 g of rhizoma gastrodiae, 15 g-20 g of radix rehmanniae preparata and 8 g-10 g of ligusticum wallichii, wherein the wine is one of kaoliang spirit, rice wine or white wine. The healthcare wine combines comprehensive efficacy of Chinese caterpillar fungus, corn cervi pantotrichum, American ginseng, Korean ginseng, ginseng, hippocamp, fructus lycii, rhizoma gastrodiae, radix rehmanniae preparata and ligusticum wallichii, and has the efficacy of invigorating vital energy and blood, adjusting physique, building fitness, invigorating kidney, strengthening yang, supplementing strength and the like; and further, the healthcare wind does not contain any chemical agent, has no side effect on a human body, can be taken for a long time, and is easily absorbed by the human body.

The invention discloses wolfberry health care wine which comprises the following components in parts by weight: 10-15 parts of wolfberry, 10-12 parts of chrysanthemum, 5-8 parts of pericarpium citri reticulatae, 4-5 parts of folium mori and 2-3 parts of leonurus. The wolfberry health care wine is obtained by soaking the components with 400-600 parts of liquor for 20-40 days. The components are jointly used, so that effects of tonifying qi, promoting blood circulation, regulating a body constitution and building a body are achieved.

The invention provides a pharmaceutical composition for treating ulcerative colitis and a micro-pill preparation with colon-targeted properties thereof, relating to the technical field of medicines. The pharmaceutical composition takes bighead atractylodes rhizome as a monarch medicine, coptis as a ministerial medicine and radix sileris as an adjuvant medicine, and is prepared from the following components in concrete parts by weight: 30-60 parts of bighead atractylodes rhizome, 30-45 parts of coptis and 30-60 parts of radix sileris. The extracts of the bighead atractylodes rhizome, coptis and radix sileris are respectively prepared into stomach-soluble micro-pills and intestine-soluble micro-pills, and then, the stomach-soluble micro-pills and the intestine-soluble micro-pills are proportionally mixed to prepare an oral colon-targeted administration system of micro-pills prepared from bighead atractylodes rhizome and coptis, thereby realizing the purpose of colon-targeted administration and better exerting the effect of the composition. The pharmaceutical composition provided by the invention and the oral colon-targeted administration system of micro-pills prepared from bighead atractylodes rhizome and coptis have the dual-treatment characteristics of treating both principal and secondary aspects of diseases and simultaneously considering overall and local aspects, and are safe and convenient in oral administration and low is cost. The animal experiment shows that the pharmaceutical composition and the oral colon-targeted administration system have an obvious treatment effect on ulcerative colitis (the treatment effect is close to or even superior to the treatment effect of a positive control medicine salicylazosulfapyridine (SASP)), and have small side effects, thus the pharmaceutical composition and the oral colon-targeted administration system can be used for preparing medicines for treating ulcerative colitis.

The invention relates to a traditional Chinese medicine used for treating spleen-kidney yang deficiency. The traditional Chinese medicine is characterized in that: the medicine comprises materials of, by weight: 30 to 50 parts of scabrous elephantfoot herb, 10 to 20 parts of cherokee rose root, 10 to 20 parts of short-horned epimedium herb, 10 to 20 parts of European verbena herb, and 10 to 20 parts of hooked spikemoss herb. As a result of experiments, with the traditional Chinese medicine provided by the invention, spleen-kidney yang deficiency can be safely and effectively treated.

The invention relates to the technical field of medicine, in particular to a colon-targeted capsule for treating ulcerative colitis and a preparation process thereof. Composed of 10-20 parts of pellets, the stomach-soluble pellets are composed of Atractylodes macrocephala volatile oil, β-cyclodextrin and pilling accelerator, etc. and colon-targeted coating material. The colon-targeted capsule of the present invention has the characteristics of treating both symptoms and root causes, high bioavailability, and releasing different components in the stomach and colon respectively, and has the advantages of safe and convenient oral administration, simple coating prescription, and industrial production. Animal experiments show that the colon-targeting capsule has obvious therapeutic effect on ulcerative colitis, and the therapeutic effect of the medium dose is close to or even better than that of the positive control drug SASP, which provides a brand-new preparation for clinical treatment of ulcerative colitis.

The invention relates to the technical field of medicine, provides a traditional Chinese medicinal composition for treating psoriasis. The traditional Chinese medicinal composition comprises the following raw materials in parts by weight: 9-60 parts of Scutellaria baicalensis, 6-45 parts of cynanchum paniculatum, 6-30 parts of Salvia miltiorrhiza, 12-45 parts of Astragalus membranaceus, and 3-15 parts of smoked plum. The invention also provides a preparation and an extraction process of the traditional Chinese medicinal composition. Among 30 psoriasis vulgaris patients treated with the traditional Chinese medicinal composition for 12 weeks, the total effective rates in treatment group and control group are 72.4% and 26.7%, respectively, resulting in statistically significant difference.

The invention provides application of a gastric medicament release system prepared from astragalus or active ingredients thereof and a colon positioning medicament release system prepared from lightyellow sophora root or active ingredients thereof in the preparation of combined medicaments for treating ulcerative colitis, and also provides a medicinal composition for treating the ulcerative colitis, which is a preparation prepared by mixing the gastric medicament release system prepared from the astragalus or active ingredients thereof and the colon positioning medicament release system prepared from the lightyellow sophora root or active ingredients thereof. Through the comparative experimental study of medicinal effect of different administration modes of each component, compared with two preparation modes of total formula colon administration and total formula oral administration, a preparation prepared by combining the oral administration of astragalus polysaccharide and saponin with the enteroclysis of matrine and oxymatrine can resist rat colon tissue pathological injury caused by trinitro-benzene-sulfonic acid obviously, improve apparent physical signs such as hematochezia, diarrhoea, anorexia, indolence and the like of animals and play a role by regulating the peripheral blood TNF-alpha level and inflammatory reactions in colon tissue, has obvious curative effect and can both regulate the integral immunologic function and resist the local inflammatory reactions in colon.

The present invention belongs to the field of biotechnology and particularly relates to a composition for the auxiliary protection of gastric mucosa and / or the remission of gastrectasia and a microecological preparation thereof. The composition for the auxiliary protection of gastric mucosa and / or the remission of gastrectasia is prepared through the synergistic combination of traditional Chinese medicines homologous in medicine and food, and probiotics. The traditional Chinese medicines homologous in medicine and food are composed of hericium erinaceus and poria cocos. The microecological preparation is prepared by the above composition and preparation auxiliary components. According to the technical scheme of the invention, the composition is prepared through the synergistic combination of traditional Chinese medicines homologous in medicine and food, and probiotics, so that the composition can well protect the gastric mucosal lesion and / or the gastrectasia. Meanwhile, the composition can adjust the balance of intestinal flora and improve the resistance. The traditional Chinese medicines homologous in medicine and food, and the probiotics play effects synergistically and promote each other, thus entirely regulating the body constitution and maintaining the normal health status.

The invention belongs to the technical field of food, and in particular relates to a composition for reducing blood sugar and fat, a drink for reducing blood sugar and fat, and a preparation method and application thereof. The hypoglycemic and lipid-lowering composition comprises the following components in parts by mass: 1-15 parts of salina extract, 1-15 parts of water chestnut extract, 1-15 parts of bitter chrysanthemum extract and 1 part of corn silk extract ~15 servings. The present invention also provides a beverage comprising the above-mentioned composition for reducing blood sugar and fat. The hypoglycemic and lipid-lowering composition provided by the present invention not only supplements nutrients such as vitamins, minerals, and amino acids, so as to regulate metabolism, enhance body immunity and disease resistance, but also has the effect of significantly reducing blood fat and blood fat. It has a good preventive and therapeutic effect on voice diseases such as pharyngitis and pharyngitis. The drink provided by the invention provides a health drink that integrates nutrition and dietotherapy for the current market, and overcomes the problem of single nutrition and function in the field of drinks in the current market.

The invention discloses healthcare wine which is mainly prepared by mixing the components in parts by weight as follows: 5 kg-7.5 kg of wine, 10 g-15 g of Chinese caterpillar fungus, 20 g-25 g of corn cervi pantotrichum, 50 g-60 g of American ginseng, 50 g-60 g of Korean ginseng, 40 g-60 g of ginseng, 6 g-8 g of hippocamp, 50 g-60 g of fructus lycii, 15 g-20 g of rhizoma gastrodiae, 15 g-20 g of radix rehmanniae preparata and 8 g-10 g of ligusticum wallichii, wherein the wine is one of kaoliang spirit, rice wine or white wine. The healthcare wine combines comprehensive efficacy of Chinese caterpillar fungus, corn cervi pantotrichum, American ginseng, Korean ginseng, ginseng, hippocamp, fructus lycii, rhizoma gastrodiae, radix rehmanniae preparata and ligusticum wallichii, and has the efficacy of invigorating vital energy and blood, adjusting physique, building fitness, invigorating kidney, strengthening yang, supplementing strength and the like; and further, the healthcare wind does not contain any chemical agent, has no side effect on a human body, can be taken for a long time, and is easily absorbed by the human body.

The invention discloses a medicine for treating a children tic disorder. The medicine is characterized by being prepared from the following raw materials by weight: 10-20g of raw dens draconis, 10-20g of selfheal, 15-30g of uncaria, 10-20g of mint, 10-20g of scrophularia ningpoensis, 10-30g of fructus forsythia, 10-30g of thunbery fritillary bulb, 10-20g of tortoise plastron, 10-30g of gastrodia elata, 10-20g of curcuma aromatic, 5-10g of platycodon grandiflorum, 10-30g of lilium brownii, 10-30g of white muscardine silkworm, 10-20g of dandelion, 5-10g of manyleaf paris rhizome, 20-30g of semen ziziphi spinosae and 10-20g of pawpaw. Due to the formula and the preparation method disclosed by the invention, the medicine is capable of clearing away heat and toxic materials, expelling phlegm to arrest coughing, tranquilizing and allaying excitement, nourishing blood, tonifying the heart, promoting qi to activate blood, soothing the liver to subside interior wind, and nourishing yin for suppressing hyperactive yang.

The invention relates to the technical field of healthcare food, and in particular relates to anticancer healthcare rapeseed oil capable of promoting blood circulation and removing stasis. The rapeseed oil is prepared from the following raw materials in parts by weight: 1300-1400 parts of rapeseed, 60-80 parts of sunflower seed, 55-60 parts of maize germ, 50-60 parts of seed of trichosanthes kirilowii maxim, 5-6 parts of lemon grass, 10-12 parts of lotus flower, 5-6 parts of oldenlandia diffusa, 10-12 parts of dark plum, 8-10 parts of asarum, 6-9 parts of herb of snow of june and 6-8 parts of flower of kudzuvine. The rapeseed oil contains various oily plant raw materials which are rich in linoleic acid, and is simultaneously added with multiple natural Chinese herbal medicinal components; the rapeseed oil adopts an environment-friendly and efficient subcritical carbon dioxide extraction technology, so that the prepared rapeseed oil is intense in smell, clear in color and rich in nutrition, and has healthcare functions of promoting blood circulation and removing stasis, clearing and activating the channels and collaterals, resisting cancer and keeping health, and is capable of regulating physical qualities of eaters; and the rapeseed oil is especially applicable to daily health care of consumers of stagnant blood constitution.

Preparation and application of a fused oral interferon expression frond for fowl are disclosed. On the basis of the conserved sequences of fowl interferon alpha and gamma genes, the interferon alpha gene having great antiviral effect and the interferon gamma gene capable of improving the immunity of the organism and enhancing the constitution of the organism are fused for expression, so that the expressed alpha+gamma fused interferon has the synergetic functions of the two. In the mean time, a dunaliella bioreactor is used as an expression system; apart from that the system is capable of expressing exogenous genes, own advantages such as rich nutrition, nontoxicity, harmlessness and the like of dunaliella are also utilized; consequently, a gene algae plant for multiple purposes is obtained; the fused oral interferon expression frond for fowl prepared from the genetically modified algae plant can be applied to the fields such as prevention or treatment of fowl viroses, fowl breeding, related feed processing industry and the like; and the fused oral interferon for fowl is good in effect, green and environment-friendly, and also low in cost.

The invention relates to a traditional Chinese medicine for treating dystrophic fatty liver. The traditional Chinese medicine for treating the dystrophic fatty liver is prepared from the following medicinal materials in parts by weight: 8 parts of largehead atractylodes rhizome, 5 parts of radish seed, 9 parts of cortex moutan, 6 parts of costustoot, 10 parts of barbary wolfberry fruit, 6 parts of cassia twig and 12 parts of Corydalis amabilis Migo. Based on clinic experiments, the traditional Chinese medicine for treating the dystrophic fatty liver, disclosed by the invention, can be used for safely and effectively treating the dystrophic fatty liver.

The invention belongs to the technical field of foods, and particularly relates to a composition capable of reducing blood sugar and reducing blood lipid, as well as a preparation method and application of the composition, a beverage capable of reducing blood sugar and reducing blood lipid, as well as a preparation method and application of the beverage. The composition capable of reducing blood sugar and reducing blood lipid comprises the following components in parts by mass of 1-15 parts of a dunaliella salina extraction solution, 1-15 parts of a water chestnut extract, 1-15 parts of a cichorium endivia extract and 1-15 parts of a corn stigma extract. The invention further provides a beverage comprising the composition capable of reducing blood sugar and reducing blood lipid. The composition capable of reducing blood sugar and reducing blood lipid, provided by the invention, can complement nutrient substances of vitamins, minerals, amino acids and the like so as to achieve the effects of regulating metabolism, strengthening organism immunity and strengthening disease resistance, has notable efficacy of reducing blood sugar and reducing blood lipid, and has good prevention and food therapy effects on voice diseases of pharyngitis, laryngopharyngitis and the like. The beverage provided by the invention is a health-care beverage integrating nutritive and food therapy effects provided for the current market, and the problem of single nutritive and functional properties of the beverage in the field of the current market can be solved.